Fatty acids increase neuronal hypertrophy of Pten knockdown neurons by Catherine J. Fricano et al.
ORIGINAL RESEARCH ARTICLE
published: 23 April 2014
doi: 10.3389/fnmol.2014.00030
Fatty acids increase neuronal hypertrophy of Pten
knockdown neurons
Catherine J. Fricano1, Tyrone DeSpenza Jr.1, Paul W. Frazel1, Meijie Li1, A. James O’Malley2,
Gary L. Westbrook3 and Bryan W. Luikart1*
1 Department of Physiology and Neurobiology, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA
2 The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA
3 The Vollum Institute, Oregon Health and Science University, Portland, OR, USA
Edited by:
Morgan Sheng, Massachusetts
Institute of Technology, USA
Reviewed by:
Yi-Ping Hsueh, Academia Sinica,
Taiwan
Carlos Bas Orth, University of
Heidelberg, Germany
Jacek Jaworski, International
Institute of Molecular and Cell
Biology, Poland
*Correspondence:
Bryan W. Luikart, Geisel School of
Medicine at Dartmouth, 1 Medical
Center Drive, Lebanon, NH 03756,
USA
e-mail: bryan.w.luikart@
dartmouth.edu
Phosphatase and tensin homolog (Pten) catalyzes the reverse reaction of PI3K by
dephosphorylating PIP3 to PIP2. This negatively regulates downstream Akt/mTOR/S6
signaling resulting in decreased cellular growth and proliferation. Co-injection of a lentivirus
knocking Pten down with a control lentivirus allows us to compare the effects of
Pten knockdown between individual neurons within the same animal. We find that
knockdown of Pten results in neuronal hypertrophy by 21 days post-injection. This neuronal
hypertrophy is correlated with increased p-S6 and p-mTOR in individual neurons. We used
this system to test whether an environmental factor that has been implicated in cellular
hypertrophy could influence the severity of the Pten knockdown-induced hypertrophy.
Implantation of mini-osmotic pumps delivering fatty acids results in increased neuronal
hypertrophy and p-S6/p-mTOR staining. These hypertrophic effects were reversed in
response to rapamycin treatment. However, we did not observe a similar increase in
hypertrophy in response to dietary manipulations of fatty acids. Thus, we conclude that by
driving growth signaling with fatty acids and knocking down a critical regulator of growth,
Pten, we are able to observe an additive morphological phenotype of increased soma size
mediated by the mTOR pathway.
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INTRODUCTION
Phosphatase and tensin homolog on chromosome 10 (Pten),
a phosphatase catalyzing the reverse reaction of phos-
phatidylinositol 3-kinases (PI3K), cleaves phosphate from
phosphatidylinositol (3,4,5)-triphosphate to yield phosphatidyli-
nositol (4,5)-bisphosphate. Thus, Pten inhibits signaling through
the Akt/mTOR/S6 pathway downstream of growth factor recep-
tors (Laplante and Sabatini, 2012). Pten dysfunction in mouse
neurons results in neuronal hypertrophy and increased excitatory
synaptic connectivity (Kwon et al., 2001, 2006; Luikart et al.,
2011b; Xiong et al., 2012). The neuronal hypertrophy seen in
mouse models parallels the macrocephaly that characterizes a
subset of patients with Pten mutations and Bannayan-Riley-
Ruvalcaba syndrome, Cowden Syndrome, and Autism Spectrum
Disorder (ASD) (Longy et al., 1998; Goffin et al., 2001; Butler
et al., 2005; McBride et al., 2010).
Further, a number of other proteins related to growth factor
signaling including Neurofibromin 1 (NF1), Tuberous Sclerosis
Complex 1 and 2 (TSC1/2), and fragile X mental retardation pro-
tein (FMRP) are associated with ASD and other co-morbidities
such as epilepsy, mental retardation, and tumor formation
(Kelleher and Bear, 2008; Bourgeron, 2009). Single gene muta-
tions are estimated to account for 10–20% of ASD cases with
no single gene accounting for more than 5% of all ASD cases
(Abrahams and Geschwind, 2008; Kelleher and Bear, 2008).
Multifactorial genetic and environmental factors likely contribute
to the etiology of ASD (Persico and Bourgeron, 2006), how-
ever, little is known about how gene/gene and gene/environment
interactions influence the expression of cellular phenotypes.
Circulating fatty acids increase p-Akt and p-mTOR signaling
in liver and muscle cells (Cao et al., 2008; Riquelme et al., 2011).
It is unknown whether a similar signaling change could occur in
the brain. Although levels of circulating fatty acids are normally
under tight metabolic regulation, increased postprandial levels
are observed in individuals with obesity and diabetes (Guo et al.,
1999; Labbe et al., 2011). Gestational diabetes and maternal obe-
sity have also been identified as risk factors for ASD (Gardener
et al., 2009, 2011; Krakowiak et al., 2012). Thus, we asked whether
fatty acids can regulate neuronal hypertrophy and signaling in
the context of Pten knockdown. Here, we demonstrate that infu-
sion of fatty acids into adult animals increased hypertrophy and
pS6/p-mTOR levels in Pten knockdown neurons. This hypertro-
phy was inhibited with the mTOR inhibitor, rapamycin. Thus,
direct infusion of fatty acids can influence the expression of cellu-
lar phenotypes in the context of a functional Pten genetic deficit.
It is unknown whether more physiologically relevant situations
could produce a similar synergistic effect.
MATERIALS AND METHODS
All protocols were approved by the Institutional Biosafety
and Institutional Animal Care and Use Committee review
boards.
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ADULT MICE VIRAL INJECTIONS
Six to 8 week old C57BL/6 female mice were anesthetized using
an isoflurane gas system (Matrix VIP 3000 isoflourane vapor-
izer). Females were used in order to decrease the chances of
the animals removing their stitches. Viruses were injected into
the dentate gyrus using a stereotaxic frame fitted to the anes-
thesia system. After treating the shaved head with betadine and
lidocaine (2.5% lidocaine and 2.5% prilocaine cream), a sagit-
tal incision was made and holes were drilled into the skull
at x, ±1.1mm, and y, −1.9mm from bregma. A 10µl Hamilton
syringe fitted with a 30 gauge needle was used to inject at z-depths
of −2.5mm and −2.3mm. Using the Quintessential Stereotaxic
Injector (Stoelting), 1µl of virus was delivered to each z-depth
at a rate of 0.3µl/min to a total of 2µl of virus per hemi-
sphere. After the injections were complete, the needle was kept
in place for 1min, and then slowly removed. The incision was
closed using sutures and treated with betadine, antibiotic oint-
ment, and lidocaine. 80µl of ketaprofen (1mg/mL) were injected
intraperitoneally.
CLONING AND VIRAL PACKAGING
All vectors and detailed.gb vector maps are available on request.
The viral packaging procedure was as previously described
(Luikart et al., 2011b). Viruses were purified by filtering viral
supernatant through a 0.45µm low protein binding syringe tip
filter and 5× PEG6000 solution was added to the supernatant to
a final concentration of 1× (final concentration is 8% PEG6000
and 0.3M NaCl). This was then mixed gently and incubated at
4◦C for 12+h (remixing occasionally). The virus-containing PEG
solution was centrifuged at 2500 g for 45min, the supernatant
then removed, and the tube spun again for 2min to remove all
the remaining supernatant. The pellet was resuspended by adding
1/100th the original volume with PBS and placed on a shaker at
RT for 30min.
SERUM FATTY ACID DETECTION
One hundred to 300 ul of blood was collected into 1.5mL tubes
from adult mice by submandibular bleeding. This blood was left
to clot overnight at 4◦C, and then spun at 6000 RPM for 20min
at 4◦C in order to separate the clot from the serum. 5 ul of each
serum sample was used to detect the total levels of free fatty
acids using a serum/plasma fatty acid detection kit (Zenbio, Cat #
SFA-1). In order to control for any hemolysis that could affect
the assay by altering the color of the serum, 5 ul of each sample
was diluted up to the total volume required for the assay using
the supplied dilution buffer. The optical density of each sample in
dilution buffer was subtracted from the optical density obtained
from running the assay.
FILLING AND IMPLANTATION OF MINI-OSMOTIC PUMPS
Adult mice were injected with mCherry control and GFP shPten
lentiviruses in the dentate gyrus. Seven days later, osmotic pumps
were implanted subcutaneously. The pumps were prepared as fol-
lows: palmitic, myristic, and palmitoleic acids (Sigma) were each
dissolved in 100% DMSO at a concentration of 14mM. Then,
40% ethanol in water was slowly added to each solution 1:1, to
make final stock concentrations of 7mM in 50%DMSO and 20%
ethanol. These 7mM stocks were combined 1:6:16 (palmitoleic:
myristic: palmitic) and loaded into the pumps (Alzet, Model
2001). The mini-osmotic pumps, which deliver one microliter
of solution per hour for one week, were filled according to the
manufacturer’s instructions in a sterile environment. The vehi-
cle pumps were filled with 50% DMSO and 20% ethanol in
water. Once the pumps were filled, they were primed in 9% ster-
ile saline for 6–12 h at 37◦C. Adult mice were anesthetized with
the isoflourane system and their backs shaved and prepped with
lidocaine and betadine. A small incision was made between the
scapulae and the pump was inserted subcutaneously. The inci-
sion was then closed with sutures and veterinary glue and 80µl of
ketaprofen (1mg/mL) was injected intraperitionally. Finally, the
incision was treated with lidocaine, betadine, and antibiotic oint-
ment. 7–10 days later, the mice were perfused and their brains
sectioned for analysis. The pumps were removed in order to verify
that they had emptied.
COMPOSITION OF FATTY ACID ADJUSTED (FAD) AND FATTY ACID
ADJUSTED, HIGH FAT (FA-HFD) DIETS
The FAD consisted of pellets containing 17.7% protein,
60.1% carbohydrate, 7.2% fat by weight plus palmi-
toleic:myristic:palmitic acids in the ratio 1:6:16 (Modified
AIN-93G diet, Harlan Laboratories). The FA-HFD consisted
pellets containing 21.0% protein, 44.9% carbohydrate, 20.3% fat
plus palmitoleic:myristic:palmitic acids in ratio 1:6:16 (Modified
TD.120122 diet, Harlan Laboratories).
RAPAMYCIN TREATMENT
Adult mice were injected with mCherry control and GFP shPten
lentiviruses and implanted 7 days later with miniosmotic pumps
containing a mixture of palmitic, palmitoleic, and myristic acids
as described above. One day after pump implantation mice
were interperitoneally injected daily for 10 days with 10mg/kg
rapamycin. A 25mg/mL stock solution of rapamycin was pre-
pared in ethanol and a working solution of 1mg/mL in 4%
ethanol, 5% Tween-80 and 5% PEG400 was prepared daily. On
the 10th day of injections mice were perfused and brain sections
were prepared for confocal analysis.
HISTOLOGY
Mice were anesthetized by injecting 600µl of 2% Avertin in
water intraperitoneally and then perfused with cold PBS with
4% sucrose, then 4% paraformaldehyde(PFA)/ 4% sucrose in
PBS through the vasculature of the mouse. After 25mL of
PFA/sucrose were pumped into the mouse, the brains were
removed and fixed overnight in PFA/sucrose at 4◦C. The next
day the brains were washed with PBS sucrose, mounted in
2.5% agarose, and sectioned into 40µm thick coronal sections
using a vibratome (Leica VT 1200 S). For soma size quantita-
tion, the slices containing the hippocampus were incubated with
mouse anti-mCherry primary antibody (1:5000, Clontech) and
rabbit anti-GFP Alexa Flour 488 conjugated (1:500, Invitrogen)
overnight at 4◦C. A Cy3-conjugated secondary antibody (1:200,
Jackson ImmunoResearch) was used to amplify mCherry. For
p-S6 (Ser235/236), p-mTOR (Ser2448) and Pten staining, the sec-
tions were stained with chicken anti-GFP (1:1000, abcam), mouse
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anti-mCherry, and rabbit anti-p-S6 (1:100, Cell Signaling) or rab-
bit anti-Pten (1:100, Cell Signaling) or rabbit anti-p-mTOR (1:50,
Cell Signaling) and incubated overnight at 4◦C. A DyLight674
conjugated secondary antibody (1:200, Jackson ImunoResearch)
was used to visualize p-S6, p-mTOR, and Pten. For Pten and p-
mTOR staining, heat antigen retrieval method was used where
slices were bathed in 10mM sodium citrate with 0.5% TWEEN-
20 and heated at 90–100◦C for 30min. Cy3, Alexa Flour 488-
and DyLight 674-conjugated secondary antibodies were applied
(1:200, Jackson ImmunoResearch) overnight at 4◦C. Sections
were mounted with Vectashield mounting medium with 4′,6-
diamidino-2-phenylindole (DAPI, Vector Laboratories).
IMAGING
Image z-stacks of granule neurons in the dentate gyrus were taken
using a Zeiss LSM 510 laser-scanning confocal microscope. An
investigator blinded to the virus status of the animal imaged and
analyzed granule neurons from anatomically equivalent sections
of the suprapyramidal blade of the dorsal portion of the dentate
gyrus. Soma images were taken using a 20× lens with a 3× zoom
or a 40× lens with a 1× zoom, at 1024 × 1024 at a 1.3µm virtual
section thickness with a z-step of 2µm.
IMAGE ANALYSIS
An investigator blind to the experimental condition imaged
and analyzed granule neurons from anatomically equivalent sec-
tions of the suprapyramidal blade of the dorsal portion of
the dentate gyrus. In Image J, soma sizes were determined by
manually tracing the circumference of each neuron at its thick-
est point in the z-stack to determine the cross sectional area.
Immunohistochemistry (IHC) images were analyzed in by cir-
cling somas and measuring the mean gray intensity value in
the blue channel for similar numbers of red control and green
shRNA neurons. The blue intensity values (representing Pten, p-
S6 or p-mTOR immunostaining) obtained from the green Pten
knockdown somas were normalized to the average blue intensity
obtained from the red control somas. The normalized intensity
was calculated by dividing the blue fluorescence intensity of each
neuron by the average intensity of the red control neurons for
each image stack. Therefore, fluorescence intensity was normal-
ized to control neurons on a per image basis, allowing us to
control for variability in staining intensity across different tissues.
STATISTICAL RESEARCH DESIGN
All values are reported as the mean of all neurons in each
group±standard error of the mean. All statistical comparisons
(p-values) were calculated using the following statistical model
unless otherwise indicated in the results. Mice were randomly
assigned to rapamycin, fatty acid or vehicle groups and cells
within each mouse were randomly infected with an shRNA
against Pten or an mCherry control virus. The number of cells
extracted from each mouse varied as opposed to being pre-
determined, depending on the level of infection of each virus.
Soma measurements of each cell were made following delivery of
the treatments. However, some of these were only available on a
subset of mice. The primary hypothesis is that the effect of Pten
is enhanced under fatty acid delivery relative to vehicle delivery.
The secondary hypothesis is that Pten knockdown has a signifi-
cant impact compared to the control treatment under fatty acid
delivery (irrespective of the effect of Pten under the control). The
secondary hypothesis is weaker in the sense that it does not iso-
late the extent that the environment impacts the effect of Pten on
neuron size.
To isolate the effects and test the hypotheses of interest in
the most robust way, we use statistical models that account for
the facts that rapamycin or fatty acid treatment is a between
mouse factor, while the Pten knockdown is a within-mouse fac-
tor, rapamycin or fatty acids and Pten knockdown are suspected
of having an interaction effect, and cells are clustered withinmice.
Such models ensure that statements of statistical precision (con-
fidence intervals and p-values) are appropriately calibrated for
the fact that observations from the same mouse are statistically
dependent and so should not be analyzed as if each cell belonged
to a different mouse. As a result, the precision of estimates related
to rapamycin or fatty acid treatments are reduced (standard errors
are larger) by the extent to which observations on the samemouse
are more similar than observations on different mice. In con-
trast, estimates of the effect of Pten knockdown are estimated
with more precision (smaller standard errors) than is a single
cell was available from many mice as treatment varies within the
same mouse and so the effect of mouse (the random variation in
the outcome variable between mice) can be extracted from the
comparison of treatments.
When analyzing outcomes measured on more than 5 mice we
used mixed-effects linear regression models with a random effect
for eachmouse; predictors for fatty acids, rapamycin, Pten knock-
down, and the interaction of these factors; and robust variance
estimation (so that the legitimacy of the inferences are not fully
reliant on the correct specification of the model). The require-
ment of more than 5 mice is imposed because with fewer mice
the variability of the outcomes between the mice is so impre-
cisely estimated there would be concerns over the robustness of
the results to the assumptions of the random effect distribution
underlying the statistical model. For analyses with fewer than 5
mice the model is structurally identical but we treat the mouse
effect as a standard regression coefficient as opposed to as a ran-
dom draw from the target population of mice. The result is that
we obtain slightly more conservative but robust estimates. The
mixed effect models (>5 mice) were estimated using the xtmixed
procedure while standard regression analyses (≤5mice) were esti-
mated using the reg procedure in Stata version 13.0. In each case
we used the robust option to compute standard errors. As well
as the estimated effects and tests of statistical significance of the
primary and secondary hypotheses, we also report the estimated
mean values averaged across the mice in this study of the out-
come under the fitted model for the genetic and pharmacological
treatment settings.
RESULTS
LENTIVIRAL Pten KNOCKDOWN RESULTS IN NEURONAL
HYPERTROPHY
C57BL/6 mice at 6–8 weeks of age were co-injected with an
FUGW-based lentivirus expressing both GFP and an shRNA tar-
geting the Pten coding region (GFP shPten) and a control virus
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expressing only mCherry (mCherry control; Figure 1A) (Lois
et al., 2002; Luikart et al., 2011b). This injection scheme allows us
to compare the morphological impact of Pten knockdown to con-
trol neurons in the same tissue. At 21 days post-injection the soma
size of Pten knockdown neurons was 108.1 ± 1.66µm2 com-
pared to 100 ± 1.75µm2 in the control (Figures 1A–C; p < 0.01,
n = 174 and 105 neurons from 5 animals, see Methods for statis-
tical model). We illustrate this data per neuron (Figure 1B) and
as paired data per animal (Figure 1C). For such data statistical
significance is determined by taking into account both the num-
ber of neurons and the number of animals (see Methods). These
data demonstrate that at 21 days post-injection, Pten knock-
down results in modest neuronal hypertrophy in adult animals.
Previous work indicated that neonatal animals are more sensi-
tive to Pten knockdown with neuronal hypertrophy detectable
by 14 days post-injection. However, in adults, no morpholog-
ical changes were detected at 14 days post-injection and overt
hypertrophy was detected by 4 months-post injection (Luikart
et al., 2011b). Thus by focusing the present study at 21 days
post-injection we are able to focus on the earliest detectable
manifestation of the Pten knockdown phenotype.
Since intensity of the different fluorophores as well as confocal
laser and detector settings could potentially affect the perceived
circumference of cells, we performed two separate experiments to
control for these variables. First, we switched the fluorophore of
the knockdown and control viruses and measured the somas of
neurons infected with an mCherry shPten virus or a GFP control
virus. This experiment resulted in a significant increase in soma
size for the mCherry knockdown neurons compared to the GFP
control neurons (Figure 1D; GFP control = 95.19 ± 1.47µm2,
mCherry shPten = 110.9 ± 2.19µm2, p < 0.0001, two-tailed t-
test, n = 111 neurons and 151 neurons from 2 animals). We also
addressed this issue by measuring the cross sectional area of cells
infected with both GFP shPten and mCherry control in the red
and green channels, and comparing the measurements from each
channel on a per cell basis. A two-tailed t-test revealed no statis-
tical difference in the measurements obtained from each channel
(Figure 1E; average soma size in red channel= 101.8± 1.94µm2,
average soma size in green channel= 101.8± 1.85µm2, p > 0.05,
two-tailed t-test, n = 113 neurons from 3 animals). These con-
trol experiments demonstrate that our data is not influenced by
differences in fluorophores.
The efficacy and specificity of the shRNA used to knockdown
Pten in these experiments has previously been characterized
(Luikart et al., 2011a). Here, we express an shRNA-insensitive
Pten overexpressing virus (GFP-Pten) in knockdown neurons
to restore function and provide definitive evidence that our
shRNAs do not have off-target effects responsible for the neuronal
hypertrophy. We first expressed GFP-Pten in the wild type back-
ground by co-injecting mCherry control with GFP-Pten virus
and performed anti-Pten immunohistochemistry (Figure 2A).
Pten-staining intensity positively correlated with GFP-intensity,
demonstrating that greater GFP fluorescence correlated with
greater Pten over-expression (Figure 2C). Cells co-infected with
mCherry shPten and GFP-Pten also demonstrated positive Pten
staining in co-labeled cells compared to cells just infected
with shPten (Figure 2B). This positive correlation between GFP
FIGURE 1 | Neuronal hypertrophy in lentiviral Pten knockdown
neurons. A lentivirus to knock down Pten (GFP shPten; green) and a
control lentivirus (mCherry control; red) were co-injected into the dentate
gyrus of young adult mice and the morphological results assessed at 21
days post-injection. (A) We observed an increase in soma size in Pten
knockdown neurons (green) compared to controls (red). (B) Plot of soma
cross-sectional area of individual control and Pten knockdown neurons.
(C) Cross-sectional area of control and knockdown neurons plotted as an
average per animal. Quantitative analysis of soma cross-sectional area from
confocal image stacks revealed that Pten knockdown results in an increase
in soma size (108.1 ± 1.66µm2 compared to 100 ± 1.75µm2 in the control;
p < 0.01, n = 174 and 105 neurons from 5 animals). (D) Pten knockdown
resulted in an increase in soma size regardless of flourophores. Mice were
co-injected with mCherry shPten and GFP control viruses, and there was a
significant increase in the soma size of mCherry shPten infected neurons
compared to GFP infected controls (GFP control = 95.19 ± 1.47µm2,
mCherry shPten = 110.9 ± 2.19µm2, p < 0.0001, two-tailed t-test, n = 111
neurons and 151 neurons from 2 animals). (E) There was no difference in
soma size when the same co-labeled neurons were analyzed in the red or
green channel (soma size in red channel = 101.8 ± 1.94µm2, average soma
size in green channel = 101.8 ± 1.85µm2, p > 0.05, two-tailed t-test,
n = 113 neurons from 3 animals).
intensity and Pten intensity in the Pten shRNA-expressing cells,
demonstrates that the GFP-Pten is shRNA-insensitive and can be
used to reconstitute Pten into Pten knockdown cells (Figure 2D).
Not only did overexpression of Pten restore Pten staining inten-
sity, but it also rescued the increase in soma size seen in
Pten knockdown neurons (Figure 2E; mCherry control = 97.8 ±
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FIGURE 2 | Over-expression of wild-type Pten in Pten deficient neurons
rescues hypertrophy caused by loss of function. An shRNA-insensitive
GFP-Pten (GFP-PTEN) was generated by altering the wobble base pairs of the
shRNA target sequence without changing the sequence of the encoded
protein. (A) Neurons co-injected with an mCherry control virus and GFP-Pten
were immuno-stained for Pten. (B) We then co-injected an mCherry labeled
Pten shRNA and GFP-Pten lentivirus and immuno-stained these neurons for
Pten. Neurons that were co-labeled (arrow heads) had an increase in Pten
staining intensity compared to those expressing the shRNA only (arrows)
(C) The GFP-Pten infected neurons (arrow heads) had a higher intensity of Pten
staining than the wildtype neurons, and there was a positive correlation
between Pten staining intensity and GFP intensity (R2 = 0.02, linear
regression analysis). (D) There was a positive correlation between GFP signal
and Pten immune-staining intensity in neurons expressing the Pten shRNA
(R2 = 0.051; linear regression analysis). The positive Pten staining in these
co-labeled neurons demonstrates that we can knockdown endogenous Pten
and replace it with shRNA-insensitive exogenous Pten. (E) To assess the
functionality of GFP-Pten in vivo we analyzed the soma size of these infected
neurons. While knocking down Pten increased the soma size of these neurons,
cells infected with the Pten shRNA and GFP-Pten had soma sizes that were not
significantly different than control cells (mCherry control = 97.8 ± 0.95µm2,
vs. shPten = 113.8 ± 1.30µm2, p < 0.001, ANOVA, n = 234 and 221 neurons
from 4 and 5 animals. shPten = 113.8 ± 1.30µm2 vs. shPten + GFP-Pten =
101.3 ± 2.10µm2, p < 0.001, ANOVA, n = 221 and 82 neurons from 5 and 4
animals. mCherry control vs. shPten + GFP-Pten, p > 0.05, ANOVA, n = 234
and 82 neurons from 4 animals per group).
0.95µm2, vs. shPten = 113.8 ± 1.30µm2, p < 0.001, ANOVA,
n = 234 and 221 neurons from 4 and 5 animals; shPten =
113.8 ± 1.30µm2 vs. shPten + GFP-Pten = 101.3 ± 2.10µm2,
p < 0.001, ANOVA, n = 221 and 82 neurons from 5 and 4
animals; mCherry control vs. shPten + GFP-Pten, p > 0.05,
ANOVA, n = 234 and 82 neurons from 4 animals each). These
results indicate that the neuronal hypertrophy associated with
Pten shRNA expression is due solely to loss of Pten expression.
p-S6 AND p-MTOR CORRELATE TO INCREASED SOMA SIZE IN Pten
KNOCKDOWN NEURONS
We next examined whether this neuronal hypertrophy correlated
with increased downstream signaling in response to Pten
knockdown. We assessed downstream signaling by normaliz-
ing the immunofluorescence intensity of p-S6 or p-mTOR in
Pten knockdown cells to neighboring control cells (Figure 3).
Although this method allows relative comparison of fluores-
cence intensity on a per-cell basis, it does not allow quanti-
tation of absolute values because a standardized linear range
of detection cannot be established. We found that there was
an increase in p-S6 staining intensity in Pten knockdown neu-
rons when compared to neighboring control neurons (Figure3A,
mCherry control = 1.00 ± 0.05, GFP shPten = 1.33 ± 0.10, p <
0.05, t-test, n = 34 and 54 neurons from 2 animals). We next
used a linear regression analysis to examine whether there was
a correlation between soma size and p-S6 intensity on a per
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FIGURE 3 | p-S6/p-mTOR correlated to increased soma size in Pten
knockdown neurons. Adult animals were co-injected with the Pten
knockdown lentivirus (GFP shPten; green) and the mCherry expressing
control virus (mCherry control; red) and immunohistochemistry was used
to evaluate p-S6 or p-mTOR expression (blue) at 21 days post-injection.
(A,B) Increased p-S6 or p-mTOR staining (blue) was observed in the
GFP shPten cells (green) when compared to neighboring mCherry
control cells (red) in the same histological section. (C) The fluorescence
intensity of the p-S6 staining was measured and normalized to the
average value obtained for control cells in each histological section. A
linear regression analysis was then used to demonstrate that there is a
positive correlation between p-S6 staining intensity and soma size. A
best fit line for the Pten knockdown neurons (solid) is shown with the
95% confidence interval (dashed) (slope = 0.018 ± 0.003; R2 = 0.3734,
p < 0.001) (D) Similar to p-S6, an increase in the p-mTOR staining
intensity (blue) was observed in Pten knockdown neurons (green). A
scatter plot of soma size x normalized p-mTOR intensity indicates a
positive correlation between soma size and p-mTOR intensity in the
Pten knockdown neurons (R2 = 0.121; p < 0.01; solid line, best fit;
dashed line, 95% confidence interval; linear regression analysis).
cell basis (Figure 3C). In control neurons, we found a posi-
tive correlation between p-S6 staining intensity and soma size
(slope = 0.0077 ± 0.003, R2 = 0.1678, p < 0.05). We also found
a positive slope for the linear regression for soma size x p-
S6 intensity of 0.018 ± 0.003 in the Pten knockdown neurons
(Figure 3C; R2 = 0.3734, p < 0.001). A comparison of the slopes
between the control and the Pten knockdown neurons did
not reveal a difference (p = 0.097). Thus the relationship of
soma size to p-S6 intensity was similar between control neu-
rons and Pten knockdown neurons. However, the magnitude
of the signaling response and associated increase in soma size
was increased in Pten knockdown neurons when compared to
controls.
Similarly, there was an increase in p-mTOR in Pten knock-
down neurons (Figure 3B; mCherry control = 1.00 ± 0.04, GFP
shPten = 1.19 ± 0.06, p < 0.05, t-test, n = 21 and 34 neurons
from 2 animals). Again the slope of the linear fit of the data indi-
cated a positive correlation between p-mTOR staining intensity
and soma size (mCherry control = 0.0045 ± 0.0039, R2 = 0.068;
GFP shPten = 0.0068 ± 0.0033, R2 = 0.121). However, this pos-
itive correlation was only significant in the Pten knockdown
neurons (Figure 3D; mCherry control p = 0.254, GFP shPten
p = 0.0472). Thus while Pten knockdown resulted in an increase
in p-mTOR staining, there was a stronger correlation of soma size
to p-S6 staining than for p-mTOR. It is important to note that an
antigen retrieval procedure must be used to stain for p-mTOR
and we found that this procedure results in tissue shrinkage and
an overall decrease in soma sizemeasurements. Thus immunohis-
tochemical staining for p-S6 is a more robust assay - displaying
better preservation of morphology, larger dynamic range, and
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improved signal to background ratio than that achieved for
p-mTOR.
FATTY ACIDS INCREASE THE EFFECTS OF Pten KNOCKDOWN ON
ADULT NEURONS
Increasing levels of circulating fatty acids can activate the
p-Akt/p-mTOR pathway in hepatocytes and cardiomyocytes
(Cao et al., 2008; Riquelme et al., 2011). To examine the effect
of fatty acids on Pten knockdown neurons we first injected the
mCherry control and GFP shPten viruses into adult mice and
implanted subcutaneous mini osmotic pumps containing a
mixture of palmitoleic, myristic, and palmitic acids (1:6:16) one
week later(Riquelme et al., 2011). Ten days post-implantation,
fatty acid treatment resulted in an increase in the effect of Pten
knockdown on soma size when compared to naïve animals
(Figures 4A–C; naïve control = 100 ± 1.75µm2, naïve shPten =
108.1 ± 1.66µm2 vs. FA control = 96.9 ± 1.04µm2, FA
shPten = 116.6 ± 1.5µm2, p < 0.05, n = 105, 174, 190, and
227 neurons from 5 animals per group). This difference can be
appreciated by observing the net change in soma size caused
by the Pten knockdown as depicted with all neurons examined
(Figure 4B) or with the data grouped by animal (Figure 4C). The
change in soma size produced by Pten knockdown in the fatty
acid treatment group approaches significance when compared to
the vehicle treated group (Veh control = 93.1 ± 1.31µm2, Veh
shPten = 104.1 ± 1.38µm2 vs. FA control = 96.9 ± 1.04µm2,
FA shPten = 116.6 ± 1.5µm2, p = 0.093, n = 164, 232, 190, and
227 neurons from 5 animals per group). Pairwise comparisons
reveal that fatty acid treated Pten knockdown neurons are
larger than knockdown neurons in the vehicle (FA shpten =
116.6 ± 1.5µm2, vs. Veh shPten = 104.1 ± 1.38µm2, p < 0.05,
n = 227 and 232 neurons from 5 animals per group). While the
amplitude of this change was similar when comparing the fatty
acid treated animals to the naïve animals, the increased variability
in the naïve shPten animals masked this effect (naïve shPten
= 108.1 ± 1.5µm2, vs. FA shPten = 116.6 ± 1.5µm2, p > 0.05,
n = 174 and 227 neurons from 5 animals per group). Thus fatty
acid treatment produced a modest increase in soma size of Pten
knockdown neurons when compared to the naïve and vehicle
treated animals.
FATTY ACIDS INCREASE p-S6 SIGNALING IN Pten KNOCKDOWN
NEURONS
To determine whether fatty acids altered signaling downstream of
Pten we injected the control and shPten viruses into 7 week old
animals and implanted mini-osmotic pumps containing palmi-
toleic, myristc, and palmitic acids 7 days post injection. There was
a significant increase in p-S6 staining in Pten knockdown neurons
in the vehicle controls as well as the fatty acid treatment groups
(Figures 5A–D; mCherry control Veh = 1.0 ± 0.02, GFP shPten
Veh = 1.28 ± 0.03, p < 0.001, n = 246 and 232 from 6 animals.
mCherry control FA= 1.0 ± 0.02, GFP shPten FA= 1.54 ± 0.05,
p < 0.001, n = 169 and 268 from 5 animals). Also, there was a
larger increase in p-S6 staining intensity in the fatty acid treated
mice than in the vehicle mice (p < 0.01). Thus, fatty acid treat-
ment significantly increased p-S6 staining in Pten knockdown
neurons compared to vehicle.
Like p-S6, there was a significant increase in p-mTOR between
control neurons and knockdown neurons in the vehicle controls
as well as the fatty acid treatment groups (Figures 5E–G; mCherry
control Veh = 1.0 ± 0.02, GFP shPten Veh = 1.32 ± 0.03, p <
0.001, n = 100 and 116 from 3 animals per group. mCherry con-
trol FA = 1.0 ± 0.02, GFP shPten FA = 1.46 ± 0.04, p < 0.001,
n = 105 and 139 from 3 animals per group). There was a trend
toward this increase being greater in the fatty acid treated cells
(Figures 5G,H, p = 0.169). As a whole these data indicate that
increases in circulating fatty acids result in increased neuronal
hypertrophy and p-S6 signaling in Pten knockdown neurons.
RAPAMYCIN INHIBITS NEURONAL HYPERTROPHY AND INCREASED
p-S6 SIGNALING IN Pten KNOCKDOWN NEURONS
Since we found increased p-S6 and p-mTOR signaling in Pten
knockdown neurons, we hypothesized that rapamycin, a potent
mTOR inhibitor, would reverse or inhibit this neuronal hyper-
trophy. We again co-injected adult mice with mCherry control
and GFP shPten viruses and implanted mini-osmotic pumps to
deliver fatty acids. After implantation of the pumps, we treated
mice with daily intraperitoneal injections of rapamycin for 10
days. Rapamycin treatment decreased the size of Pten knock-
down neurons compared to untreated Pten knockdown neu-
rons (Figure 6C; Veh shPten = 107.4 ± 1.52µm2, Veh shPten +
rapa = 99.36 ± 1.00µm2, p < 0.001, n = 188 and 272 neurons
from 4 animals per group). Further, rapamycin treated Pten
knockdown neurons were essentially the same size as wild type
neurons (Figure 6C; Veh control = 94.13 ± 1.36, Veh shPten +
rapa = 99.36 ± 1.00, p = 0.119, n = 134 and 272 neurons from
4 animals per group) demonstrating that inhibiting mTOR pre-
vents this neuronal hypertrophy and restores soma size to that of
the controls.
Rapamycin was also capable of decreasing the somal hyper-
trophy of the Pten knockdown neurons of fatty acid treated
mice (Figure 6D; fatty acid shPten = 116.6 ± 1.50µm2, fatty
acid shPten + rapa = 97.38 ± 1.23µm2, p < 0.05, n = 277 and
264 neurons from 4 animals each). The rapamycin treatment
of Pten knockdown cells compared to fatty acid treated control
cells reveals no difference in soma size (Figure 6D; FA shPten +
rapa= 97.38 ± 1.23µm2, FA control= 96.86 ± 1.04, p = 0.454,
n = 190 and 264 neurons from 4 animals each), showing that
rapamycin was capable of restoring the most hypertrophic cells
to the size of wild-type neurons.
The effect of rapamycin on p-S6 levels was more robust than
on soma size. There was actually a decrease in p-S6 signaling in
rapamycin treated knockdown neurons compared to rapamycin
treated controls (Figure 6E, left; Veh control + rapa = 1.00 ±
0.02, Veh shPten + rapa = 0.089 ± .02, p < 0.001, n = 220 and
272 neurons from 4 animals per group). There was also a decrease
in p-S6 signaling in rapamycin treated knockdown cells compared
to non-treated knockdown cells (Figure 6E, right; Veh shPten =
1.28 ± 0.03, Veh shPten + rapa = 0.89 ± 0.02, p < 0.001, n =
232 neurons from 6 animals and 272 neurons from 4 animals).
Therefore, rapamycin eliminated the increase in p-S6 signaling
produced by Pten knockdown. In vehicle treated animals, Pten
knockdown resulted in an increase of p-S6 staining intensity from
1.00 ± 0.02 to 1.28 ± 0.03 (p < 0.001). Rapamycin treated Pten
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FIGURE 4 | Fatty acids increase neuronal hypertrophy in Pten
knockdown neurons. (A) Adult mice were injected with the mCherry
control (red) and the GFP shPten (green) lentiviruses. At seven days
post-injection they were implanted with mini- pumps containing a mixture
of palmitic, palmitoleic, and myristic acid. Fatty acid treated knockdown
neurons were significantly larger than their neighboring controls (FA
shPten = 116.6 ± 1.50µm2, FA control = 96.9 ± 1.04µm2, p < 0.001,
n = 227 and 190 neurons from 4 animals). (B) Soma size is displayed for
individual control and knockdown neurons in the naïve, vehicle, and fatty
acid treated groups. Pten knockdown resulted in neuronal hypertrophy
regardless of treatment (naïve control = 100 ± 1.75µm2, naïve
shPten = 108.1 ± 1.66µm2, p < 0.001, n = 105 and 174 neurons from 5
animals; Veh control = 93.1 ± 1.31µm2, Veh shPten = 104.1 ± 1.38µm2,
p < 0.001, n = 164 and 232 neurons from 5 animals; FA
control = 96.9 ± 1.04µm2, FA shPten = 116.6 ± 1.5µm2, p < 0.001,
n = 190 and 227 neurons from 4 animals) and fatty acid treatment
exacerbated this effect (veh shPten vs. FA shPten, p < 0.05). (C)
Displaying the data grouped by animal demonstrates an increase in soma
size of the fatty acid treated neurons compared to wild type (naïve
control = 100 ± 1.75µm2, naïve shPten = 108.1 ± 1.66µm2 vs. FA
control = 96.9 ± 1.04µm2, FA shPten = 116.6 ± 1.5µm2, p < 0.05,
n = 105, 174, 190, and 227 neurons from 5 and 5 animals). However,
comparison of the change in soma size produced by Pten in the fatty
acid treatment group and the vehicle treated was not quite significant
(Veh control = 93.1 ± 1.31µm2, Veh shPten = 104.1 ± 1.38µm2 vs. FA
control = 96.9 ± 1.04µm2, FA shPten = 116.6 ± 1.5µm2, p = 0.093,
n = 164, 232, 290, and 227 neurons from 5 and 5 animals). Overall,
these data demonstrate a trend toward increased hypertrophy of
knockdown cells in the fatty acid treated cells compared to the
knockdown cells in the vehicle and naïve controls.
knockdown neurons had a decrease in p-S6 staining when com-
pared to wild type neurons (p < 0.001). Even with the addition
of fatty acids, rapamycin was still able to decrease the level of p-S6
signaling in knockdown cells compared to neighboring controls
(Figures 6A,B,F, right; FA shPten = 1.54 ± 0.05, FA shPten +
rapa = 0.85 ± 0.02, p < 0.001, n = 268 and 264 neurons from
5 and 4 animals respectively). Therefore, rapamycin treatment is
able to prevent increases in p-S6 signaling caused by Pten knock-
down in both vehicle treated and fatty acid treated animals. This
provides evidence that this phenotype is mediated through the
mTOR pathway.
DIETARY FATTY ACIDS HAVE NO EFFECT ON Pten KNOCKDOWN
PHENOTYPES
We next examined the effects of dietary fatty acid manip-
ulation on Pten knockdown neurons. We injected 7 week
old mice with the mCherry control and the GFP shPten
lentiviruses, then placed the animals on either normal rodent
chow, a fatty acid adjusted diet (FAD) containing 7.2% fat
by weight with palmitoleic:myristic:palmitic acids in the ratio
1:6:16 (modified AIN-93G, Harlan Laboratories), or a fatty acid
adjusted high fat diet (FA-HFD) containing 20.3% fat with
palmitoleic:myristic:palmitic acids in ratio 1:6:16 (TD.120122,
Harlan Laboratories). At 21 days post-injection Pten knockdown
increased soma size for all three diets examined (Figure 7A; nor-
mal chow mCherry control = 100 ± 1.75µm2, normal chow
GFP shPten = 108.1 ± 1.66µm2, p < 0.001, n = 105 and 174
neurons from 5 animals. FAD mCherry control = 99.0 ±
3.00µm2, GFP shPten FAD = 115.0 ± 2.05µm2, p < 0.001, n =
48 and 84 neurons from 2 animals. mCherry control FA-HFD
= 99.8 ± 1.40µm2, GFP shPten FA- HFD = 109.8 ± 1.63µm2,
p < 0.01, n = 110 and 136 neurons from 3 animals). There was
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FIGURE 5 | Circulating fatty acids increase p-S6 and p-mTOR signaling in
Pten knockdown neurons. Adult animals were co-injected with the Pten
knockdown lentivirus (GFP shPten; green) and the mCherry expressing
control virus (mCherry control; red). Mini-osmotic pumps were implanted
seven days post-injection and then seven days after implantation
immunohistochemistry was used to evaluate p-S6 or p-mTOR expression
(blue). (A) A slight increase in p-S6 expression (blue) was detected in Pten
knockdown neurons (green) when compared to control neurons (red) in
vehicle treated animals. (B) In animals treated with fatty acids, a marked
increase in p-S6 staining (blue) was observed in the GFP shPten cells (green)
when compared to the mCherry control cells (red only). (C) Plot of individual
p-S6 intensities for each knockdown and control neuron normalized to the
p-S6 intensity in controls. (D) Pten knockdown resulted in an increase in p-S6
signaling in knockdown neurons compared to controls in the vehicle control
as well as the fatty acid treatment groups (mCherry control Veh = 1.0 ± 0.02,
GFP shPten Veh = 1.28 ± 0.03, p < 0.001, n = 246 and 232 neurons from 6
animals. mCherry control FA = 1.0 ± 0.02, GFP shPten FA = 1.54 ± 0.05,
p < 0.001, n = 169 and 268 neurons from 5 animals). There was a significant
increase in the p-S6 intensity of fatty acid treated neurons compared to
vehicle neurons (p < 0.01) demonstrating that fatty acids increased p-S6
signaling beyond what was seen with Pten knockdown. (E) Similar to p-S6,
an increase in the p-mTOR staining intensity (blue) was observed in Pten
knockdown neurons (green) vs. mCherry control neurons (red) in the vehicle
treated group. (F) p-mTOR activation was more apparent in the Pten shRNA
neurons (green) when compared to control neurons (red) after fatty acid
treatment. (G) Plot of individual p-mTOR intensities for each knockdown and
control neuron normalized to the p-mTOR intensity in controls. (H) Pten
knockdown resulted in an increase in p-mTOR signaling in knockdown
neurons compared to controls in the vehicle and fatty acid treatments
(mCherry control Veh = 1.0 ± 0.02, GFP shPten Veh = 1.32 ± 0.03,
p < 0.001, n = 100 and 116 from 3 animals; mCherry control FA = 1.0 ± 0.02,
GFP shPten FA = 1.46 ± 0.04, p < 0.001, n = 105 and 139 from 3 animals).
However, there was no significant difference between the vehicle and fatty
acid treated neurons (p = 0.169).
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FIGURE 6 | Rapamycin Inhibits Neuronal Hypertrophy and Increased
p-S6 signaling Caused by Pten Knockdown (A) Pten knockdown neurons
treated with fatty acids (green) have an increase in soma size and p-S6
intensity (blue) compared to neighboring control neurons (red). (B) Treating
these fatty acid exposed, Pten knockdown neurons with rapamycin (green)
inhibits this increase in soma size and increase in p-S6 staining (blue)
compared to control neurons (red). (C) In vehicle treated neurons, there is
still an increase in soma size when comparing the knockdown neurons to
control neurons (Vehicle control = 94.13 ± 1.36, Vehicle shPten = 107.4 ±
1.52, p < 0.001, n = 134 and 188 neurons from 4 animals). There is also
still an increase in soma size when comparing the knockdown neurons to
the control neurons in the rapamycin treated cells (Veh control + rapa =
91.03 ± 0.86, Veh shPten + rapa = 99.36 ± 1.00,p < 0.001, n = 220 and
272 cells from 4 animals). However, there is no difference between the
Veh shPten + rapa cells and the Veh control cells (p > 0.05), showing that
rapamycin was able to rescue the soma size of knockdown cells to that of
the untreated controls. There is also a significant difference between Veh
shPten cells and the Veh shPten + rapa cells (p < 0.001, right panel),
demonstrating that rapamycin treatment reduced the size of Pten
knockdown neurons. (D) Like the vehicle, there is also still a significant
increase in soma size in fatty acid treated Pten knockdown neurons
compared to their controls in the rapamycin treated and non-treated
groups (FA control = 96.86 ± 1.04, FA shPten = 116.6 ± 1.50, p < 0.001,
n = 190 and 277 neurons from 4 animals; FA control + rapa
= 87.23 ± 0.94, FA shPten + rapa = 97.38 ± 1.23, p < 0.001, n = 207 and
264 neurons from 4 animals). There was no significant difference between
fatty acid treated control neurons and fatty acid treated Pten knockdown
neurons treated with rapamycin, demonstrating that even with fatty acid
treatment, rapamycin is still able to rescue the soma size of knockdown
neurons to that of controls (FA control vs. FA shPten + rapa, p > 0.05).
Finally, there was a significant difference between fatty acid treated Pten
knockdown neurons and fatty acid treated Pten knockdown neurons
treated with rapamycin (FA shPten vs. FA shPten + rapa, p < 0.05, right
panel), demonstrating that rapamycin is able to rescue the soma size of
fatty acid treated Pten knockdown neurons. (E) In vehicle treated animals,
there is an increase in p-S6 signaling in knockdown neurons compared to
controls (Veh control = 1.00 ± 0.02, Veh shPten = 1.28 ± 0.03, p < 0.001,
n = 246 and 232 neurons from 6 animals). With rapamycin treatment,
there is a reversal of this effect and a robust decrease in p-S6 signaling in
the knockdown cells (Veh control + rapa = 1.00 ± 0.02, Veh shPten +
rapa = 0.89 ± 0.02, p < 0.001, n = 220 and 272 neurons from 4 animals).
Therefore, there is a significant difference in p-S6 signaling in vehicle
rapamycin treated animals and untreated animals (p < 0.001). (F) Again,
there is an increase in p-S6 signaling in fatty acid treated knockdown
neurons compared to controls (fatty acid control = 1.0 ± 0.02, fatty acid
shPten = 1.54 ± 0.05, n = 169 and 268 neurons from 5 animals). However,
even with fatty acid treatment, there is still a significant decrease in p-S6
staining in rapamycin treated knockdown neurons compared to controls (FA
control + rapa = 1.00 ± 0.01, FA shPten + rapa = 0.85 ± 0.02, p < 0.01,
n = 207 and 264 neurons from 4 animals). Therefore, there is a significant
decrease in p-S6 signaling in fatty acid and rapamycin treated neurons
compared to fatty acid treatment alone (right, p < 0.001).
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FIGURE 7 | Dietary fatty acid manipulations do not alter neuronal size.
(A) Three diet groups displayed by neuron show a significant increase in
the FAD compared to the control diet, but not the FA-HFD compared to
the control diet. (B)Soma sizes of Pten knockdown neurons did not differ
between adult mice fed a normal diet, a fatty acid adjusted diet (FAD) or
a fatty acid adjusted high fat diet (FA-HFD). However, there was still an
increase in soma size between the Pten knockdown and control neurons
and previously seen (normal chow mCherry control = 100 ± 1.75µm2,
normal chow GFP shPten = 108.1 ± 1.66µm2, p < 0.001, n = 105 and
174 neurons from 5 animals. FAD mCherry control = 99.0 ± 3.00µm2,
GFP shPten FAD = 115.0 ± 2.05µm2, p < 0.001, n = 48 and 84 neurons
from 2 animals. mCherry control FA-HFD = 99.8 ± 1.40µm2, GFP shPten
FA- HFD = 109.8 ± 1.63µm2, p < 0.01, n = 110 and 136 neurons from 3
animals). For the FA-HFD, there was no evidence for an increase in soma
size further than Pten knockdown alone, but there was a significant
increase in the FAD (regular chow vs. FAD, p < 0.05) (C) Levels of free
fatty acids (FFA) were measured in the serum of adults fed normal chow,
the FAD, and the FA-HFD. None of the diet manipulations increased the
circulating FFA levels of the adults (Adult fed regular chow = 486.8 ±
53.94µM FFA, Adult fed FAD = 525.6 ± 206.6µM FFA, Adult fed FA-
HFD = 811.6 ± 56.23µM FFA, p > 0.05, one-way ANOVA, n = 9, 4, and 4
animals, respectively).
no change in soma size of control neurons in response to diet.
Interestingly, the FAD significantly increased the soma size of
knockdown neurons over that of the regular diet knockdown neu-
rons (p < 0.05, Figure 7B), but there was no increase in hypertro-
phy of the HF-FAD knockdown neurons. We examined the levels
of free fatty acids in the blood of these animals and found that
neither the FAD nor the FA-HFD significantly increased the level
of circulating fatty acids in the adults (Figure 7C; Adult fed reg-
ular chow = 486.8 ± 53.94µM FFA, Adult fed FAD = 525.6 ±
206.6µMFFA, Adult fed FA-HFD= 811.6 ± 56.23µMFFA; p >
0.05, One-Way ANOVA, n = 9, 4, and 4 animals, respectively).
Overall wild-type animals were resistant to fluctuations in circu-
lating fatty acid levels caused by dietary changes and these diets
did not affect the phenotypic expression of Pten knockdown.
DISCUSSION
By co-injecting a control virus with an shRNA-based Pten knock-
down virus we were able to compare the effects of Pten knock-
down between neurons in the same animal. Using this system we
can measure the morphological effects of Pten knockdown and
compare immunohistochemical staining intensities by normaliz-
ing to levels seen in control neurons within the same histological
section. This allows us to eliminate variability in staining that
occurs across sections. With such a tightly-controlled system
we were able to detect neuronal hypertrophy by 21 days post-
injection. Further, the neuronal hypertrophy correlated with
increased p-S6 and p-mTOR in individual neurons and was
inhibited with rapamycin treatment.
Using this system we chose to determine whether circulat-
ing fatty acids could alter the expression of the Pten knockdown
phenotype. Circulating fatty acids are able to pass through the
blood-brain barrier, so we hypothesized that they could have an
effect on neurons (Mitchell and Hatch, 2011). Manipulating the
amount of circulating palmitic, palmitoleic, and myristic acids
induces cardiac hypertrophy through mTOR signaling (Riquelme
et al., 2011). We find that the introduction of this mixture of fatty
acids results in a larger increase in soma size in Pten knockdown
neurons than seen in naïve adults or vehicle controls. Further the
combination of fatty acid infusion and Pten knockdown resulted
in greater increases in p-S6 than seen in vehicle controls.
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The physiological relevance of experiments involving the
direct infusion of fatty acids into animals is unclear. We therefore
attempted to manipulate fatty acid levels through diet. The FAD
in which the composition of fatty acids was altered but the over-
all fat content was similar to the normal rodent chow resulted
in an increase in soma size in Pten knockdown neurons simi-
lar to direct fatty acid infusion. However, the fatty acid adjusted
high fat diet with both increased fat content and altered fatty acid
composition did not have an effect on soma size when compared
to normal chow. Interestingly, neither of these dietary manipu-
lations significantly elevated the levels of circulating fatty acids
presumably because metabolic processes regulate levels of cir-
culating fatty acids despite fluctuations in dietary intake. Such
metabolic regulation may be affected in individuals with obesity
or diabetes such that dietary fat intake results in significant fluctu-
ations of circulating fatty acid levels (Guo et al., 1999; Labbe et al.,
2011). Thus chronic dietary manipulation or dietary manipula-
tion in obese/diabetic models may reveal an interaction with Pten
knockout.
Although metabolic mechanisms regulating endogenous free
fatty acid levels are complicated, experimental elevation of these
levels in adult animals enhanced the effects of Pten knockdown.
There are a number of potential mechanisms by which fatty
acid elevation could mediate this effect. Insulin is able to pro-
mote phosphorylation and activation of AKT/mTOR (Scott et al.,
1998). Although fatty acids can suppress or potentiate insulin
secretion depending on the specific fatty acid species and experi-
mental context (Yaney and Corkey, 2003), it has been suggested
that increasing levels of fatty acids could promote growth by
regulating insulin sensitivity (Riquelme et al., 2011). Increasing
fatty acids could also affect the production of arachidonic acid
or prostaglandin E2, both of which can increase mTOR signaling
(Kuehn et al., 2011; Wen et al., 2012). Finally, it has been specu-
lated that palmitic acid could activate the PI3K pathway directly
via an unknown receptor (Pu et al., 2011).
Although our data do not address the exact mechanisms by
which fatty acids potentiate growth signaling, we do demonstrate
that we are able to inhibit the hypertrophy and p-S6 signaling with
rapamycin, an mTOR inhibitor. Interestingly rapamycin reduced
p-S6 levels in Pten knockdown neurons to the levels less than
that of control neurons. This could indicate other processes at
work to compensate against the increased downstream signaling
in the Pten knockdown neurons. We also demonstrate a molec-
ular link between increased fatty acid levels and the neuronal
hypertrophy caused by Pten knockdown through the elevation of
p-S6/p-mTOR. However, the overall magnitude of this effect is
quite small and the dietary manipulation data is inconsistent. It
remains to be determined whether long-term fatty acid manipu-
lations could produce a more robust effect and whether this effect
is relevant to the pathophysiology of Autism Spectrum Disorder.
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